The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays ...

In 2024, coverage for obesity drugs increased to 44% among employers with 500 or more workers, compared to 41% last year, the ...

Taking anti-obesity drugs has led some U.S. adults to throw away more food than they tossed before starting the medications, a new study has found.

President-elect Donald J. Trump is set to nominate Robert F. Kennedy Jr. to lead the Health and Human Services Department, ...

Inspired by the jets of water that squids use to propel themselves through the ocean, a team developed an ingestible capsule that releases a burst of drugs directly into the lining of the stomach or ...

The restructuring follows the company's receipt of a letter from the FDA citing "deficiencies" in its approval application for diabetes drug Zynquista.

Local researchers are actively seeking volunteers to participate in clinical trials aimed at improving health outcomes.

GLP-1 RAs to assist with weight loss have exploded in popularity. Researchers are working to identify which patients will ...

Northwell Health partnered with Stacker to see which states have seen the biggest declines in senior health, using data from ...

New research has found that nearly 137 million adults—or more than half of all U.S. adults—are eligible for semaglutide ...